Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+T cells

被引:0
|
作者
Gomez Aleza, Clara [1 ]
Nguyen, Bastien [2 ]
Yoldi, Guillermo [1 ]
Ciscar, Marina [3 ]
Barranco, Alexandra [3 ]
Hernandez Jimenez, Enrique [1 ]
Maetens, Marion [2 ]
Salgado, Roberto [2 ]
Zafeiroglou, Maria [1 ]
Pellegrini, Pasquale [1 ]
Venet, David [2 ]
Garaud, Soizic [4 ]
Trinidad, Eva M. [1 ]
Benitez, Sandra [1 ]
Munoz, Purificacion [1 ]
Walzer, Thierry [8 ]
Planelles, Lourdes [9 ]
Penninger, Josef [10 ,11 ]
Azim, Hatem A., Jr. [5 ,12 ]
Loi, Sherene [6 ,7 ]
Piccart, Martine
Sotiriou, Christos [2 ]
Gonzalez Suarez, Eva [3 ]
机构
[1] IDIBELL, Bellvitge Biomed Res Inst, Oncobell, Barcelona, Spain
[2] Univ Libre Bruxelles, Inst Jules Bordet, Breast Canc Translat Res Lab J C Heuson, Brussels, Belgium
[3] Spanish Natl Canc Res Ctr CNIO, Mol Oncol, Madrid, Spain
[4] Univ Libre Bruxelles, Inst Jules Bordet, Mol Immunol Unit, Brussels, Belgium
[5] Univ Libre Bruxelles, Inst Jules Bordet, Dept Med Oncol, Brussels, Belgium
[6] Walter & Eliza Hall Inst Med Res, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[7] Royal Melbourne Hosp, Melbourne, Vic, Australia
[8] Univ Claude Bernard, Ctr Int Rech Infectiol, CIRI, Inserm U1111,CNRS, Lyon, France
[9] Parc Cientif Univ, BiOncotech Therapeut, Valencia, Spain
[10] Univ British Columbia, Inst Life Sci, Vancouver, BC, Canada
[11] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, Vienna, Austria
[12] Amer Univ Beirut, Dept Med, Div Hematol Oncol, Beirut, Lebanon
关键词
Animal models; cancer immunology; immunotherapy; in vivo tumor models; molecular immunology;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P-0736
引用
收藏
页码:239 / 239
页数:1
相关论文
共 50 条
  • [41] CD8+CD39+T Cells Mediate Anti-Tumor Cytotoxicity in Bladder Cancer
    Zhu, Wenjie
    Zhao, Zihan
    Feng, Baofu
    Yu, Wenhao
    Li, Ji
    Guo, Hongqian
    Yang, Rong
    ONCOTARGETS AND THERAPY, 2021, 14 : 2149 - 2161
  • [42] YTHDF2 promotes tumor immune evasion by inhibiting CD8+T cell-mediated anti-tumor immunity
    Ma, Shoubao
    Xiao, Sai
    Caligiuri, Michael
    Yu, Jianhua
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [43] Tumor-specificity of tumor-infiltrating CD8+t cells determines the potential of immune checkpoint inhibitors in breast cancer.
    Kim, Jee Ye
    Lee, Yong Joon
    Jeon, Seung Hyuck
    Nam, Heejin
    Jung, Jae Hyung
    Kim, Seung Il
    Shin, Eui-Cheol
    CANCER RESEARCH, 2021, 81 (13)
  • [44] Semaglutide as a potent activator of anti-tumor immune response in breast cancer
    Stanisavljevic, Isidora
    Jovanovic, Ivan
    Markovic, Bojana Simovic
    Corovic, Irfan
    Krajnovic, Tamara
    Mijatovic, Sanja
    Pavlovic, Sladjana
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 748 - 748
  • [45] The anti-tumor immune response in breast cancer: Update and therapeutic perspectives
    Ladoire, Sylvain
    Derangere, Valentin
    Arnould, Laurent
    Thibaudin, Marion
    Coudert, Bruno
    Lorgis, Veronique
    Desmoulins, Isabelle
    Chaix, Marie
    Fumoleau, Pierre
    Ghiringhelli, Francois
    ANNALES DE PATHOLOGIE, 2017, 37 (01) : 133 - 141
  • [46] Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo
    Cao, Yu
    Feng, Yong-Hui
    Gao, Li-Wei
    Li, Xiao-Ying
    Jin, Quan-Xiu
    Wang, Yu-Ying
    Xu, Ying-Ying
    Jin, Feng
    Lu, Shi-Long
    Wei, Min-Jie
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 70 : 110 - 116
  • [47] Patritumab augments anti-tumor immune response of adoptive transfer of autologous T cells for breast cancer PDX models
    Kotake, Takeshi
    Suzuki, Eiji
    Pu, Fengling
    Kataoka, Tatsuki
    Hirata, Masahiro
    Nishimura, Tomomi
    Iida, Kei
    Liu, Li
    Toi, Masakazu
    ANNALS OF ONCOLOGY, 2019, 30 : 143 - 143
  • [48] MHCII-expressing breast cancer cells can induce anti-tumor immune response
    Li, Mei
    Mccaw, Tyler R.
    Meza-Perez, Selene
    Randall, Troy D.
    Weinmann, Amy
    Buchsbaum, Donald J.
    Forero, Andres
    LoBuglio, Albert F.
    CANCER RESEARCH, 2016, 76
  • [49] CDK4/6 inhibition directly enhances an anti-tumor immune response in breast cancer
    DeCristo, Molly J.
    Goel, Shom
    Watt, April C.
    BrinJones, Haley
    Sceneay, Jaclyn
    Li, Ben
    Ubellacker, Jessalyn M.
    Xie, Shaozhen
    Ramm, Susanne
    Kim, Hye-Jung
    McAllister, Sandra S.
    Zhao, Jean J.
    CANCER RESEARCH, 2017, 77
  • [50] The Role of Regulatory T Cells in the Modulation of Anti-Tumor Immune Response
    Radosavljevic, Gordana D.
    Jovanovic, Ivan P.
    Kanjevac, Tatjana V.
    Arsenijevic, Nebojsa N.
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2013, 141 (3-4) : 262 - 267